Cite
HARVARD Citation
Heerspink, H. et al. (2019). Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial. Lancet. 393 (10184), pp. 1937-1947. [Online].